Page last updated: 2024-08-22

misonidazole and Benign Neoplasms, Brain

misonidazole has been researched along with Benign Neoplasms, Brain in 81 studies

Research

Studies (81)

Timeframe	Studies, this research(%)	All Research%
pre-1990	44 (54.32)	18.7374
1990's	7 (8.64)	18.2507
2000's	6 (7.41)	29.6817
2010's	22 (27.16)	24.3611
2020's	2 (2.47)	2.80

Authors

Authors	Studies
Arakawa, Y; Fushimi, Y; Nakamoto, Y; Sakata, A; Shimizu, Y	1
Abdo, RA; Bentourkia, M; Fernandez, P; Lamare, F	1
Brenner, AJ; Clarke, GD; Floyd, JR; Fox, PT; Huang, S; Hyun, H; Jerabek, PA; Lee, EQ; Michalek, JE; Muzi, M; Reardon, DA; Schmainda, KM; Wen, PY	1
Barré, L; Bekaert, L; Bernaudin, M; Bordji, K; Branger, P; Collet, S; Constans, JM; Emery, E; Guillamo, JS; Lechapt-Zalcman, E; Levallet, G; Manrique, A; Petit, E; Ponte, K; Valable, S	1
Hatazawa, J; Hiraka, T; Hosoya, T; Kanoto, M; Kirii, K; Matsuda, K; Sakurada, K; Sonoda, Y; Sugai, Y; Toyoguchi, Y	1
Al Jaberi, M; Förster, S; Gempt, J; Göttler, J; Kluge, A; Lukas, M; Meyer, B; Preibisch, C; Pyka, T; Ringel, F; Schlegel, J; Shi, K; Wiestler, B; Zimmer, C	1
Barré, L; Bernaudin, M; Chakhoyan, A; Collet, S; Constans, JM; Delcroix, N; Guillamo, JS; Kauffmann, F; Lechapt-Zalcman, E; MacKenzie, ET; Petit, E; Touzani, O; Valable, S	1
Andronesi, OC; Barboriak, D; Ellingson, B; Fink, J; Gerstner, ER; Greco, E; Hanna, L; Kim, D; Kostakoglu, L; Mankoff, D; Mintz, A; Muzi, M; Prah, M; Ratai, EM; Richards, T; Schmainda, K; Sorensen, G; Zhang, Z	1
Hirata, K; Houkin, K; Kobayashi, H; Shiga, T; Terasaka, S; Yamaguchi, S	1
Gambrell, JV; Mistry, N; Quarles, CC; Stokes, AM	1
Cao, WD; Haba, R; Kawai, N; Lin, W; Maeda, Y; Miyake, K; Nishiyama, Y; Ogawa, D; Tamiya, T; Yamamoto, Y	1
Hawkins-Daarud, AJ; Hendrickson, K; Jacobs, J; Kinahan, P; Krohn, KA; Mrugala, MM; Neal, ML; Rockhill, JK; Rockne, RC; Swanson, KR; Trister, AD	1
Fink, JR; Krohn, KA; Mankoff, DA; McLaughlin, LJ; Muzi, JP; Muzi, M; O'Sullivan, JN; Peterson, LM; Rajendran, JG	1
Hatanaka, KC; Hirata, K; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S; Yuzawa, S	1
Barboriak, DP; Eikman, EA; Ellingson, BM; Fink, JR; Gerstner, ER; Greco, E; Hanna, L; Kostakoglu, L; Mankoff, DA; Mintz, A; Muzi, M; Prah, M; Ratai, EM; Schmainda, KM; Sorensen, AG; Zhang, Z	1
Hattori, N; Hirata, K; Ito, YM; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S	1
Hirata, K; Houkin, K; Ishi, Y; Kobayashi, H; Kobayashi, K; Motegi, H; Shiga, T; Tamaki, N; Terasaka, S; Toyonaga, T; Yamaguchi, S	1
Alvord, EC; Chakraborty, G; Hadley, J; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR; Szeto, MD	1
Kawai, N; Kudomi, N; Maeda, Y; Miyake, K; Nishiyama, Y; Okada, M; Tamiya, T; Yamamoto, Y	1
Alessio, AM; Alvord, EC; Anderson, AR; Chakraborty, G; Champley, K; Claridge, J; Gu, S; Kinahan, PE; Krohn, KA; Muzi, M; Rockne, R; Spence, AM; Swanson, KR	1
Barré, L; Bernaudin, M; Delamare, J; Divoux, D; Marteau, L; Petit, E; Roussel, S; Sobrio, F; Toutain, J; Valable, S	1
Hattori, N; Hirata, K; Houkin, K; Kobayashi, H; Kuge, Y; Magota, K; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Yamaguchi, S	1
Aga, F; Kawai, N; Kudomi, N; Maeda, Y; Nishiyama, Y; Ono, Y; Yamamoto, Y	1
Katoh, N; Kuge, Y; Okamoto, S; Onimaru, R; Shiga, T; Shirato, H; Suzuki, R; Takeuchi, W; Tamaki, N; Tsuchiya, K; Yasuda, K	1
Hanzawa, H; Hatano, T; Kuge, Y; Kuno, N; Nishijima, K; Sakamoto, T; Tamaki, N; Zhao, S; Zhao, Y	1
Ametamey, SM; Bruehlmeier, M; Roelcke, U; Schubiger, PA	1
Berlangieri, SU; Cher, LM; Fabinyi, G; Hannah, A; Lawrentschuk, N; Murone, C; O'Keefe, GJ; Papenfuss, A; Ramdave, S; Sachinidis, JI; Scott, AM	1
Lee, ST; Scott, AM	1
Adamsen, TC; Krohn, KA; Link, JM; Muzi, M; O'Sullivan, F; Rajendran, JG; Rockhill, JK; Rostomily, RC; Silbergeld, DL; Spence, AM; Swanson, KR; Swanson, PE; Yagle, KJ	1
Allen, J; Edwards, MS; Levin, VA; Ortega, J; Vestnys, P; Wara, WM	1
Fulton, DS; Geggie, PH; Johnson, E; Mielke, B; Moody, J; Muller, PJ; Shin, KH; Tanasichuk, H; Thomas, H; Urtasun, RC	1
Kärcher, KH; Kogelnik, HD; Stadler, B; Szepesi, T	1
Handa, H; Oda, Y; Ono, K; Otsuka, S; Suda, K; Takeuchi, J; Yamashita, J; Yumitori, K	1
Gutin, PH; Phillips, TL; Wara, WM; Wilson, CB	1
Strike, TA; Walker, MD	1
Chapman, JD	1
Carabell, S; Goodman, RL; Nelson, DF; Nelson, JS; Schoenfeld, D; Wasserman, T; Weinstein, AS	1
Onoyama, Y	1
Dische, S	1
Davis, DR; Diener, MD; Gillespie, BW; Nelson, DF; Phillips, TL; Stetz, J; Wasserman, T	1
Dar'ialova, SL; Kiseleva, ES	1
Mitsuhashi, N; Mogi, K; Nakajima, N; Niibe, H; Okazaki, A; Saito, K; Sakaino, K; Sudo, H; Suzuki, Y; Yonome, I	1
Bleehen, NM; Gleave, JR; Grant, RM; Hardy, DG; Holmes, AE; Jones, DH; Roberts, JT; Workman, P	1
Gi, H; Handa, H; Oda, Y; Ono, K; Otsuka, S; Suda, K; Takeuchi, J; Yamashita, J	1
Siemann, DW; Wallen, CA; Wheeler, KT; Wolf, KL	1
Morrissey, S; Siemann, DW; Wheeler, KT; Wolf, K	1
Ammon, J; Bamberg, M; Calcanis, A; Godehardt, E; Herbst, M; Keim, H; Kleibel, F; Makoski, HB; Potthoff, PC; Sack, H; Schlegel, G; Schnepper, E; Weidtman, V; Zülch, KJ	1
Ang, KK; Chenal, C; Fauchon, F; Goffin, JC; Horiot, JC; Notter, G; Raps, J; van der Schueren, E; van Glabbeke, M; van Peperzeel, H; Vessière, M	1
Blasberg, R; Fenstermacher, J; Horowitz, M; Kornblith, P; Molnar, P; Pleasants, R; Strong, J	1
Bleehen, NM	1
Bamberg, M; Scherer, E; Streffer, C; Tamulevicius, P	2
Bleehen, NM; Gleave, JR; Hawkins, TD; Holmes, AE; Lewin, WS; Plowman, PN; Treip, CS; Watson, JV; Wiltshire, CR	1
Phillips, TL; Stetz, J; Wasserman, TH	1
Otsuka, S	1
Bruno, LA; Carabell, SC; Chang, CH; Goodman, RL; Richter, MP; Weiler, CB; Weinstein, AS	1
Ash, DV; Smith, MR	1
Bleehen, NM; Wiltshire, CR; Workman, P	1
Allen, N	1
Asbell, SO; Chang, CH; Martz, K; Mohiuddin, M; Phillips, T; Swift, PS; Wara, W	1
Allalunis-Turner, MJ; Franko, AJ; Parliament, MB; Wolokoff, BG	1
Chan, F; Chan, JG; Cher, L; Hall, C; Hill, J; Kaye, A; Sachinidis, JI; Scott, AM; Stylli, S; Tochon-Danguy, HJ	1
Kärcher, KH; Kogelnik, HD; Seitz, W; Szepesi, T	1
Chapman, D; Koziol, D; Partington, J; Rabin, H; Urtasun, RC	1
Ash, DV; Bugden, RD; Smith, MR	1
Brückner, V	1
Budinger, TF; Gilbert, JC; Mathis, CA; Prados, MD; Valk, PE	1
Curry, B; Feldstein, M; Fulton, DS; Hanson, J; Huyser-Wierenga, D; Johnson, ES; Mielke, B; Scott-Brown, I; Urtasun, RC	1
Wallen, CA; Wheeler, KT; Wong, KH	1
Asbell, S; Isaacson, S; Komarnicky, LT; Martz, K; Phillips, TL; Urtasun, R	1
Awschalom, M; Cohen, L; Hendrickson, FR; Kurup, PD; Mansell, J; Nelson, JS; Pajak, TF; Rosenberg, I; Ten Haken, RK	1
Ganz, JC; Hagen, S; Hatlevoll, R; Kristiansen, K; Lindegaard, KF; Mella, O; Nesbakken, R; Ringkjöb, R; Rosengren, B; Torvik, A	1
Fulton, DS; McKinnon, S; Tanasichuk, H; Urtasun, RC	1
Gutin, PH; Nelson, DF; Saunders, WM; Sheline, GE; Urtasun, RC	1
Carabell, S; Chang, CH; Diener-West, M; Goodman, R; Nelson, DF; Nelson, JS; Sause, WT; Schoenfeld, D; Weinstein, AS	1
Cohen, L; Griffin, TW; Hendrickson, FR; Kurup, PD; Mansell, J; Nelson, JS; Pajak, TF	1
Edwards, MS; Levin, VA; Liu, HC; Wallner, KE; Wara, WM	1
Curry, B; Fulton, D; Geggie, PH; Johnson, E; Mielke, B; Muller, PJ; Shin, KH; Tanasichuk, H; Thomas, H; Urtasun, RC	1
Inoue, H; Koizumi, H; Murata, M; Nakamura, M; Niibe, H; Tamura, M; Yonome, I	1

Reviews

5 review(s) available for misonidazole and Benign Neoplasms, Brain

Article	Year
Usefulness of FMISO-PET for glioma analysis. Neurologia medico-chirurgica, 2013, Volume: 53, Issue:11 Topics: Adult; Animals; Brain Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Misonidazole; Oxygen; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results	2013
Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole. Seminars in nuclear medicine, 2007, Volume: 37, Issue:6 Topics: Animals; Brain Ischemia; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorine Radioisotopes; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Misonidazole; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stroke	2007
[Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors]. Meditsinskaia radiologiia, 1984, Volume: 29, Issue:9 Topics: Brain Neoplasms; Combined Modality Therapy; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Metronidazole; Misonidazole; Mouth Neoplasms; Neoplasms; Radiation-Sensitizing Agents; Rectal Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms	1984
Recent and current investigations of radiation therapy of malignant gliomas. Seminars in oncology, 1986, Volume: 13, Issue:1 Topics: Brachytherapy; Brain; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Glioma; Helium; Humans; Hyperbaric Oxygenation; Hyperthermia, Induced; Mesons; Metronidazole; Middle Aged; Misonidazole; Neon; Neutrons; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy, High-Energy	1986
Fast neutron therapy for malignant astrocytomas. A review. Journal of neuro-oncology, 1986, Volume: 4, Issue:2 Topics: Astrocytoma; Brain; Brain Neoplasms; Fast Neutrons; Humans; Misonidazole; Neutrons	1986

Trials

26 trial(s) available for misonidazole and Benign Neoplasms, Brain

Article	Year
Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging. Australasian physical & engineering sciences in medicine, 2019, Volume: 42, Issue:4 Topics: Brain Neoplasms; Carotid Artery, Common; Glioblastoma; Humans; Image Processing, Computer-Assisted; Misonidazole; Positron-Emission Tomography; Time Factors; Tumor Burden; Tumor Hypoxia	2019
[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Biomarkers, Tumor; Brain Neoplasms; Cerebral Blood Volume; Disease-Free Survival; Female; Glioma; Humans; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Positron-Emission Tomography; Radiosurgery; Tumor Hypoxia	2017
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy. PloS one, 2018, Volume: 13, Issue:6 Topics: Aged; Brain; Brain Neoplasms; Female; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Prognosis; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; ROC Curve; Tumor Hypoxia	2018
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:3 Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Female; Glioblastoma; Humans; Male; Methionine; Middle Aged; Misonidazole; Positron-Emission Tomography; Tumor Burden	2011
¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:5 Topics: Adult; Aged; Anaplasia; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Misonidazole; Neoplasm Grading; Positron-Emission Tomography	2012
Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:11 Topics: Adult; Aged; Blood Flow Velocity; Brain; Brain Neoplasms; Female; Humans; Hypoxia, Brain; Male; Middle Aged; Misonidazole; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Water	2004
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:3 Topics: Adult; Aged; Brain; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic	2006
Misonidazole combined with hyperfractionation in the management of malignant glioma. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9 Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic; Glioblastoma; Glioma; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy Dosage; Random Allocation	1984
Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9 Topics: Brain Neoplasms; Clinical Trials as Topic; Female; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Prognosis; Radiation-Sensitizing Agents; Random Allocation	1984
Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study. European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:1 Topics: Adult; Brain Neoplasms; Clinical Trials as Topic; Double-Blind Method; Female; Glioma; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Prognosis; Radiotherapy Dosage; Time Factors	1983
A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study. International journal of radiation oncology, biology, physics, 1983, Volume: 9, Issue:8 Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Drug Administration Schedule; Glioma; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Prospective Studies; Radiation-Sensitizing Agents; Random Allocation	1983
[Clinical trials of hypoxic cell sensitizer misonidazole]. Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:6 Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Misonidazole; Neoplasms; Nitroimidazoles; Oxygen; Random Allocation; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	1983
Clinical trials with hypoxic cell sensitizers-the European experience. Progress in clinical and biological research, 1983, Volume: 132D Topics: Animals; Brain Neoplasms; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Methods; Misonidazole; Neoplasms; Nitroimidazoles; Urinary Bladder Neoplasms	1983
Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16? International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9 Topics: Brain Neoplasms; Clinical Trials as Topic; Dexamethasone; Female; Glioma; Humans; Male; Middle Aged; Misonidazole; Nervous System Diseases; Nitroimidazoles; Phenytoin; Radiation-Sensitizing Agents	1984
[Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study]. Strahlentherapie, 1982, Volume: 158, Issue:8 Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic; Germany, West; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Postoperative Care; Radiotherapy Dosage	1982
The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies. Cancer clinical trials, 1980,Fall, Volume: 3, Issue:3 Topics: Brain Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Glioma; Head and Neck Neoplasms; Humans; Kinetics; Misonidazole; Phenobarbital; Phenytoin; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms	1980
Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies. The British journal of radiology, 1981, Volume: 54, Issue:640 Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Esophageal Neoplasms; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles	1981
A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma. British journal of cancer, 1981, Volume: 43, Issue:4 Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Random Allocation	1981
Radiation Therapy Oncology Group clinical trials with misonidazole. Cancer, 1981, May-15, Volume: 47, Issue:10 Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Glioma; Head and Neck Neoplasms; Humans; Misonidazole; Nausea; Nervous System Diseases; Nitroimidazoles; Radiotherapy Dosage; Random Allocation; Vomiting	1981
CT characteristics of patients with brain metastases treated in RTOG study 79-16. International journal of radiation oncology, biology, physics, 1993, Jan-15, Volume: 25, Issue:2 Topics: Brain Neoplasms; Combined Modality Therapy; Humans; Misonidazole; Prospective Studies; Radiotherapy; Survival Analysis; Tomography, X-Ray Computed	1993
Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study. Journal of neuro-oncology, 1992, Volume: 14, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Astrocytoma; Brain; Brain Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Misonidazole; Multivariate Analysis; Necrosis; Proportional Hazards Models; Radiation Injuries; Radioisotope Teletherapy; Radiotherapy Dosage; Severity of Illness Index; Skin Diseases; Survival Analysis; Survival Rate; Treatment Outcome	1992
A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Prospective Studies; Radiation-Sensitizing Agents; Survival Analysis	1991
Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party. Journal of neuro-oncology, 1990, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Misonidazole; Multivariate Analysis; Prognosis; Proportional Hazards Models	1990
Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of Cancer, 1985, Jul-01, Volume: 56, Issue:1 Topics: Actuarial Analysis; Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Misonidazole; Nitroimidazoles; Radiotherapy Dosage; Random Allocation; Scandinavian and Nordic Countries; Telencephalon	1985
A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:10 Topics: Adult; Aged; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Glioma; Humans; Middle Aged; Misonidazole; Prognosis; Radiation-Sensitizing Agents; Random Allocation	1986
Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer, 1985, Aug-15, Volume: 56, Issue:4 Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Prospective Studies; Random Allocation; Time Factors	1985

Other Studies

50 other study(ies) available for misonidazole and Benign Neoplasms, Brain

Article	Year
18 F-FMISO PET of an Intracranial Tuberculoma : A Great Mimicker. Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4 Topics: Brain Neoplasms; Humans; Misonidazole; Positron Emission Tomography Computed Tomography; Tuberculoma, Intracranial; Tuberculosis	2023
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and Scientific reports, 2021, 04-07, Volume: 11, Issue:1 Topics: Adult; Aged; Bevacizumab; Biomarkers, Pharmacological; Brain Neoplasms; Cerebral Blood Volume; Drug Resistance, Neoplasm; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Progression-Free Survival; Tumor Hypoxia; Young Adult	2021
Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography. Acta radiologica (Stockholm, Sweden : 1987), 2018, Volume: 59, Issue:2 Topics: Brain Neoplasms; Cerebellum; Female; Humans; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Sensitivity and Specificity; Tumor Hypoxia	2018
Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study. NMR in biomedicine, 2017, Volume: 30, Issue:11 Topics: Aged; Brain Neoplasms; Cell Hypoxia; Female; Glioma; Humans; Image Enhancement; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Positron-Emission Tomography	2017
FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas. Scientific reports, 2017, 08-31, Volume: 7, Issue:1 Topics: Adult; Aged; Brain Mapping; Brain Neoplasms; Female; Glioblastoma; Gray Matter; Humans; Hypoxia, Brain; Male; Middle Aged; Misonidazole; Perfusion Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve; White Matter	2017
Nitrite induces the extravasation of iron oxide nanoparticles in hypoxic tumor tissue. NMR in biomedicine, 2014, Volume: 27, Issue:4 Topics: Animals; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Extravasation of Diagnostic and Therapeutic Materials; Ferric Compounds; Misonidazole; Nanoparticles; Nitrites; Positron-Emission Tomography; Rats; Rats, Wistar; Time Factors	2014
Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Female; Glioma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A	2014
A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET. Journal of the Royal Society, Interface, 2015, Feb-06, Volume: 12, Issue:103 Topics: Aged; Brain Neoplasms; Glioma; Humans; Hypoxia; Male; Misonidazole; Models, Biological; Positron-Emission Tomography; Precision Medicine; Radiation-Sensitizing Agents; Radiography	2015
18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aorta; Brain Neoplasms; Cerebellum; Disease Progression; Female; Heart; Humans; Hypoxia; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neoplasms; Oxygen; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome	2015
(18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cerebellum; Female; Humans; Male; Middle Aged; Misonidazole; Necrosis; Positron-Emission Tomography	2016
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI. Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Oct-15, Volume: 22, Issue:20 Topics: Adult; Aged; Biomarkers; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Hypoxia	2016
Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:4 Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Oxygen; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment. PloS one, 2016, Volume: 11, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Bevacizumab; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2016
Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. Cancer research, 2009, May-15, Volume: 69, Issue:10 Topics: Adult; Brain Neoplasms; Cell Division; Computer Simulation; Contrast Media; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Misonidazole; Neoplasm Invasiveness; Positron-Emission Tomography	2009
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images. Mathematical medicine and biology : a journal of the IMA, 2012, Volume: 29, Issue:1 Topics: Adult; Brain Neoplasms; Cell Proliferation; Computer Simulation; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Male; Mathematical Concepts; Misonidazole; Models, Biological; Necrosis; Neoplasm Invasiveness; Neovascularization, Pathologic; Positron-Emission Tomography; Precision Medicine; Radiopharmaceuticals; User-Computer Interface	2012
Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model. Nuclear medicine and biology, 2011, Volume: 38, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Biological Transport; Brain; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cerebrovascular Circulation; Disease Models, Animal; Glioma; Indoles; Kinetics; Magnetic Resonance Imaging; Misonidazole; Neovascularization, Pathologic; Permeability; Positron-Emission Tomography; Pyrroles; Rats; Sunitinib; Treatment Outcome	2011
Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas. Nuclear medicine communications, 2012, Volume: 33, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Child, Preschool; Female; Glioma; Humans; Hypoxia; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Radiation-Sensitizing Agents; Retrospective Studies; Young Adult	2012
[18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer. International journal of radiation oncology, biology, physics, 2013, Jan-01, Volume: 85, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Case-Control Studies; Cell Hypoxia; Female; Humans; Laryngeal Neoplasms; Lutetium; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Multimodal Imaging; Nasopharyngeal Neoplasms; Nasopharynx; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Semiconductors; Silicates; Thyroid Neoplasms; Tomography, X-Ray Computed	2013
Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma. International journal of oncology, 2013, Volume: 42, Issue:3 Topics: Animals; Autoradiography; Biological Transport; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Glucose; Glucose Transporter Type 1; Hexokinase; Hypoxia-Inducible Factor 1; Ki-67 Antigen; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Wistar; Tissue Distribution	2013
Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, May-01, Volume: 14, Issue:9 Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Disease Progression; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Misonidazole; Positron-Emission Tomography; Regression Analysis	2008
5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas: a pilot study of the Brain Tumor Research Center and the Childrens Cancer Group. Neurosurgery, 1984, Volume: 14, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cobalt Radioisotopes; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Fluorouracil; Glioblastoma; Glioma; Humans; Hydroxyurea; Lomustine; Male; Misonidazole; Prognosis; Radioisotope Teletherapy	1984
[Radiosensitizing effect of misonidazole on intracranially transplanted tumors in mice and its clinical application (author's transl)]. Neurologia medico-chirurgica, 1982, Volume: 22, Issue:5 Topics: Adult; Aged; Animals; Brain Neoplasms; Cobalt Radioisotopes; Female; Glioma; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage	1982
Hypoxic cell radiosensitizers in the treatment of malignant brain tumors. Neurosurgery, 1980, Volume: 6, Issue:5 Topics: Animals; Brain Neoplasms; Cricetinae; DNA; Glioblastoma; Humans; Hypoxia; In Vitro Techniques; Metronidazole; Misonidazole; Oxygen Consumption; Radiation-Sensitizing Agents	1980
Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs. Cancer clinical trials, 1980,Summer, Volume: 3, Issue:2 Topics: Adrenal Cortex Hormones; Barbiturates; Brain Neoplasms; Drug Interactions; Female; Glioma; Half-Life; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Phenytoin	1980
The detection and measurement of hypoxic cells in solid tumors. Cancer, 1984, Dec-01, Volume: 54, Issue:11 Topics: Anaerobiosis; Animals; Brain Neoplasms; Carbon Radioisotopes; Cell Line; Cell Survival; Cricetinae; Cricetulus; Humans; Hypoxia; Lung; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasms; Radiation-Sensitizing Agents; Rats; Tomography, Emission-Computed	1984
[Clinical evaluation of radiosensitizing effects of misonidazole]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1984, Jul-25, Volume: 44, Issue:7 Topics: Brain Neoplasms; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles	1984
The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in man. The British journal of radiology, 1983, Volume: 56, Issue:671 Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Time Factors	1983
[Local administration of radiosensitizer misonidazole]. No to shinkei = Brain and nerve, 1983, Volume: 35, Issue:3 Topics: Adult; Aged; Animals; Astrocytoma; Brain Neoplasms; Dogs; Drug Implants; Female; Glioma; Humans; Injections, Spinal; Kinetics; Male; Mice; Mice, Inbred C57BL; Misonidazole; Nitroimidazoles; Rats; Silicone Elastomers; Uterine Neoplasms	1983
Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole. British journal of cancer, 1984, Volume: 49, Issue:6 Topics: Animals; Brain Neoplasms; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Lomustine; Misonidazole; Nitroimidazoles; Oxygen; Rats; Skin Neoplasms; Tumor Stem Cell Assay	1984
In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole. British journal of cancer, 1984, Volume: 49, Issue:6 Topics: Animals; Brain Neoplasms; Carmustine; Cell Survival; Cells, Cultured; Drug Synergism; Misonidazole; Nitroimidazoles; Rats	1984
Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. A pilot feasibility study of the Radiotherapy Group of the EORTC. International journal of radiation oncology, biology, physics, 1982, Volume: 8, Issue:10 Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Female; Glioma; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Pilot Projects; Prognosis; Radiotherapy Dosage; Radiotherapy, High-Energy	1982
Regional [14C]misonidazole distribution in experimental RT-9 brain tumors. Cancer research, 1983, Volume: 43, Issue:8 Topics: Animals; Autoradiography; Brain Neoplasms; Cerebrovascular Circulation; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Rats; Rats, Inbred F344; Regional Blood Flow; Tissue Distribution	1983
[Radiosensitizing effect of misonidazole in radiotherapy for intracranial tumors]. Nihon geka hokan. Archiv fur japanische Chirurgie, 1982, Nov-01, Volume: 51, Issue:6 Topics: Adolescent; Adult; Aged; Animals; Brain Neoplasms; Child; Drug Implants; Female; Glioma; Humans; Male; Mice; Middle Aged; Misonidazole; Nitroimidazoles; Silicone Elastomers	1982
Misonidazole and radiotherapy to treat malignant glioma: a phase II trial of the radiation therapy oncology group. International journal of radiation oncology, biology, physics, 1981, Volume: 7, Issue:1 Topics: Astrocytoma; Brain Neoplasms; Drug Evaluation; Glioma; Humans; Misonidazole; Nitroimidazoles; Prognosis	1981
[Clinical experiences with the radiosensitizer Misonidazol (author's transl)]. Strahlentherapie, 1981, Volume: 157, Issue:8 Topics: Adolescent; Adult; Aged; Brain Neoplasms; Dexamethasone; Drug Interactions; Esophageal Neoplasms; Exanthema; Female; Glioma; Half-Life; Humans; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Phenytoin	1981
Causes of apparent low levels of misonidazole in human tumours. Clinical radiology, 1980, Volume: 31, Issue:2 Topics: Adipose Tissue; Animals; Brain Neoplasms; Humans; In Vitro Techniques; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Misonidazole; Muscles; Neoplasms; Nitroimidazoles; Rats	1980
Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity. British journal of cancer, 1980, Volume: 41, Issue:2 Topics: Brain Neoplasms; Half-Life; Humans; Kinetics; Misonidazole; Nitroimidazoles; Phenytoin	1980
Experimental therapy of brain tumors. Progress in clinical and biological research, 1980, Volume: 39 Topics: Animals; Brain Neoplasms; Carmustine; Cell Line; Methods; Metronidazole; Misonidazole; Neoplasms, Experimental; Radiation-Sensitizing Agents; Rats; Sulfhydryl Compounds; Vitamin A	1980
Variable presence of hypoxia in M006 human glioma spheroids and in spheroids and xenografts of clonally derived sublines. British journal of cancer, 1998, Volume: 78, Issue:10 Topics: Animals; Brain Neoplasms; Clone Cells; Deuterium; Glioma; Humans; Hypoxia; Mice; Mice, SCID; Misonidazole; Necrosis; Radiation-Sensitizing Agents; Spheroids, Cellular; Transplantation, Heterologous; Tumor Cells, Cultured	1998
Imaging and quantitation of the hypoxic cell fraction of viable tumor in an animal model of intracerebral high grade glioma using [18F]fluoromisonidazole (FMISO). Nuclear medicine and biology, 2002, Volume: 29, Issue:2 Topics: Animals; Brain Neoplasms; Cell Hypoxia; Fluorine Radioisotopes; Glioma; Intestinal Mucosa; Kidney; Liver; Male; Misonidazole; Rats; Rats, Wistar; Tissue Distribution; Tomography, Emission-Computed	2002
[Clinical experiences with the radiation-sensitizing agent misonidazole]. Strahlentherapie. Sonderbande, 1978, Volume: 75 Topics: Brain Neoplasms; Cardiovascular System; Central Nervous System; Digestive System; Drug Eruptions; Eye; Female; Humans; Liver; Male; Misonidazole; Neoplasms; Nitroimidazoles	1978
New side effect of the hypoxic cell sensitizer, misonidazole. Cancer treatment reports, 1979, Volume: 63, Issue:1 Topics: Aged; Brain Neoplasms; Drug Eruptions; Drug Therapy, Combination; Female; Glioblastoma; Humans; Male; Misonidazole; Nitroimidazoles	1979
Distribution of misonidazole in human tumours and normal tissues. British journal of cancer, 1979, Volume: 39, Issue:5 Topics: Brain Neoplasms; Breast Neoplasms; Female; Genital Neoplasms, Female; Humans; Male; Misonidazole; Neoplasms; Nitroimidazoles; Thyroid Diseases; Tissue Distribution; Urinary Bladder Neoplasms	1979
Photosensitizers and radiosensitizers in dermatology and oncology. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Sep-22, Volume: 56, Issue:13 Topics: Brain Neoplasms; DNA; Humans; Methoxsalen; Metronidazole; Misonidazole; Mycosis Fungoides; Photochemistry; Photochemotherapy; Psoriasis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin Diseases; Skin Neoplasms; Ultraviolet Rays; Ultraviolet Therapy	1979
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:12 Topics: Adult; Astrocytoma; Brain Neoplasms; Cell Hypoxia; Fluorine Radioisotopes; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Tomography, Emission-Computed	1992
2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells. Journal of neuro-oncology, 1991, Volume: 11, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cell Line; Cell Survival; Drug Synergism; Etanidazole; Lomustine; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Inbred F344; Streptozocin; Tumor Stem Cell Assay	1991
Fast neutrons and misonidazole for malignant astrocytomas. International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:4 Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Misonidazole; Neutrons; Nitroimidazoles	1985
Misonidazole and CCNU chemotherapy for recurrent primary brain tumor. Journal of neuro-oncology, 1987, Volume: 4, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Glioblastoma; Glioma; Humans; Lomustine; Middle Aged; Misonidazole; Neoplasm Recurrence, Local	1987
Retreatment of pediatric brain tumors with radiation and misonidazole. Results of a CCSG/RTOG phase I/II study. Cancer, 1986, Oct-15, Volume: 58, Issue:8 Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Ependymoma; Female; Humans; Male; Medulloblastoma; Misonidazole; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis	1986
Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer. Journal of cancer research and clinical oncology, 1985, Volume: 109, Issue:3 Topics: Animals; Brain Neoplasms; Dose-Response Relationship, Radiation; Glioma; Misonidazole; Nitroimidazoles; Oxygen; Rats	1985